3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
25
Breast Neoplasms
22
Salivary Gland Neoplasms
3
Prostate Adenocarcinoma
2
Neoplasm Metastasis
2
Breast Neoplasms, Male
2
Triple Negative Breast Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunctions, Psychological
1
Primary Dysautonomias
1
Patient Compliance
1
PSA Level Greater Than Two
1
Kidney Diseases
1
Hypertension
1
Hormone Sensitive Prostate Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
HER2-positive Breast Cancer
1
HER2 Negative Breast Cancer
1
Castrate Sensitive Prostate Cancer
1
Bulbo-Spinal Atrophy, X-Linked
1
Anatomic Stage I Breast Cancer AJCC v8
1
Advanced Breast Cancer
1
Interventions
Paclitaxel
69
Bevacizumab
62
Carboplatin
53
pembrolizumab
46
olaparib
32
Specimen Handling
27
Gemcitabine
27
Cyclophosphamide
26
Magnetic Resonance Spectroscopy
24
liposomal doxorubicin
22
Cisplatin
21
niraparib
20
Taxes
18
Nivolumab
18
fludarabine
17
Topotecan
17
Biopsy
17
Doxorubicin
14
Immunoglobulin G
12
Fulvestrant
12
Disulfides
12
Oxaliplatin
10
mirvetuximab soravtansine
9
durvalumab
9
aldesleukin
9
Surveys and Questionnaires
9
Ipilimumab
9
Fluorouracil
9
Blood Specimen Collection
9
cemiplimab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Goserelin
×
1 year
×
Clear all
No trials found.